National Center For Research Resources; Notice of Closed Meeting, 62814 [2011-26218]

Download as PDF 62814 Federal Register / Vol. 76, No. 196 / Tuesday, October 11, 2011 / Notices describing the best test methods for proprietary name evaluation. II. Comments Interested persons may submit to the Division of Dockets Management (see ADDRESSES) either electronic or written comments regarding the pilot project or this document. It is only necessary to send one set of comments. It is no longer necessary to send two copies of mailed comments. Identify comments with the docket number found in brackets in the heading of this document. Received comments may be seen in the Division of Dockets Management between 9 a.m. and 4 p.m., Monday through Friday. Dated: October 4, 2011. David Dorsey, Acting Associate Commissioner for Policy and Planning. [FR Doc. 2011–26099 Filed 10–7–11; 8:45 am] BILLING CODE 4160–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Health Resources and Services Administration Advisory Council on Blood Stem Cell Transplantation; Notice of Meeting mstockstill on DSK4VPTVN1PROD with NOTICES In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Public Law 92–463), notice is hereby given of the following meeting: Name: Advisory Council on Blood Stem Cell Transplantation (ACBSCT). Date and Time: November 08, 2011, 10 am to 4 pm EDT. Place: The meeting will be via audio conference call and Adobe Connect Pro. Status: The meeting will be open to the public. Purpose: Pursuant to Public Law 109–129, 42 U.S.C. 274k (section 379 of the Public Health Service Act, as amended,) the Advisory Council on Blood Stem Cell Transplantation (ACBSCT) advises the Secretary of HHS and the Administrator, HRSA, on matters related to the activities of the C.W. Bill Young Cell Transplantation Program (Program) and the National Cord Blood Inventory (NCBI) Program. Agenda: The Council will hear reports from five ACBSCT Work Groups: Cord Blood Bank Collections, Realizing the Potential of Cord Blood, Scientific Factors Necessary to Define a Cord Blood Unit as High Quality, Cord Blood Thawing and Washing, and Access to Transplantation. The Council also will hear presentations and discussions, which may include the following topics: CAO study and report; FDA licensure and unmet need. The public can join the meeting by: 1. Calling Conference Phone Number: 888– 790–3527 and providing Participant Code: 8064893, for the audio portion, AND VerDate Mar<15>2010 20:47 Oct 07, 2011 Jkt 226001 2. Connecting to the ACBSCT Adobe Connect Pro Meeting for the visual portion using the following URL: https:// hrsa.connectsolutions.com/acbsct/ (if the link does not work, copy and paste it into your browser). The conference call leader is Patricia A. Stroup. Call (301) 443–0437 or send an e-mail to ptongele@hrsa.com if you are having trouble connecting to the meeting site. Participants should call no later than 9:45 am EDT in order for logistics to be set up. If you have never attended an Adobe Pro Connect Meeting, please test your connection using the following URL: https://hrsa.connect solutions.com/common/help/en/support/ meeting_test.htm. For quick overview, please access: https:// www.adobe.com/go/connectpro_overview. Those planning to participate are asked to complete and submit an online registration form by visiting our Web site at https:// www.ACBSCT.com and selecting the tab titled ‘‘Registration.’’ Individuals with no Internet access should request the registration form by contacting Gabrielle Kardolus at (301) 585–1261 or at Gabrielle.Kardolus@luxcg.com and fax the registration form to Gabrielle Kardolus at (301) 585–7741. The registration deadline is November 2, 2011. The next face-to-face ACBSCT meeting is planned for Spring 2012. Details regarding the next meeting will be published in a subsequent Federal Register notice. Public Comment: Persons interested in providing an oral presentation should submit a written request, along with a copy of their presentation to: Passy Tongele, DoT, Healthcare Systems Bureau (HSB), Health Resources and Services Administration (HRSA), Room 12C–06, 5600 Fishers Lane, Rockville, Maryland 20857 or e-mail: ptongele@hrsa.gov. Requests should contain the name, address, telephone number, e-mail address, and any business or professional affiliation of the person desiring to make an oral presentation. Groups having similar interests are requested to combine their comments and present them through a single representative. The allocation of time may be adjusted to accommodate the level of expressed interest. Persons who do not file an advance request for a presentation, but desire to make an oral statement, may announce it at the time of the public comment period. Public participation and ability to comment will be limited to space and time as it permits. For Further Information Contact: Patricia Stroup, Executive Secretary, Healthcare Systems Bureau, Health Resources and Services Administration, 5600 Fishers Lane, Room 12C–06, Rockville, Maryland 20857; telephone (301) 443–1127. Dated: October 3, 2011. Reva Harris, Acting Director, Division of Policy and Information Coordination. [FR Doc. 2011–26168 Filed 10–7–11; 8:45 am] BILLING CODE 4165–15–P PO 00000 Frm 00060 Fmt 4703 Sfmt 4703 DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Center For Research Resources; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Center for Research Resources Special Emphasis Panel. Date: November 9, 2011. Time: 8 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: Hilton Rockville, 1750 Rockville Pike, Rockville, MD 20852. Contact Person: Martha F. Matocha, PhD, Scientific Review Officer, Office of Review, National Center for Research Resources, National Institutes of Health, 6701 Democracy Blvd., 1 Democracy Plaza, Rm. 1070, Bethesda, MD 20892, 301–435–0813, matocham@mail.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research; 93.371, Biomedical Technology; 93.389, Research Infrastructure, 93.306, 93.333; 93.702, ARRA Related Construction Awards., National Institutes of Health, HHS) Dated: October 4, 2011. Jennifer S. Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. 2011–26218 Filed 10–7–11; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Biomedical Imaging and Bioengineering; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections E:\FR\FM\11OCN1.SGM 11OCN1

Agencies

[Federal Register Volume 76, Number 196 (Tuesday, October 11, 2011)]
[Notices]
[Page 62814]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-26218]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Center For Research Resources; Notice of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Center for Research Resources 
Special Emphasis Panel.
    Date: November 9, 2011.
    Time: 8 a.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Hilton Rockville, 1750 Rockville Pike, Rockville, MD 
20852.
    Contact Person: Martha F. Matocha, PhD, Scientific Review 
Officer, Office of Review, National Center for Research Resources, 
National Institutes of Health, 6701 Democracy Blvd., 1 Democracy 
Plaza, Rm. 1070, Bethesda, MD 20892, 301-435-0813, 
matocham@mail.nih.gov.

(Catalogue of Federal Domestic Assistance Program Nos. 93.306, 
Comparative Medicine; 93.333, Clinical Research; 93.371, Biomedical 
Technology; 93.389, Research Infrastructure, 93.306, 93.333; 93.702, 
ARRA Related Construction Awards., National Institutes of Health, 
HHS)

    Dated: October 4, 2011.
Jennifer S. Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2011-26218 Filed 10-7-11; 8:45 am]
BILLING CODE 4140-01-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.